These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 22710573)

  • 1. Hepatic stem cells and transforming growth factor β in hepatocellular carcinoma.
    Majumdar A; Curley SA; Wu X; Brown P; Hwang JP; Shetty K; Yao ZX; He AR; Li S; Katz L; Farci P; Mishra L
    Nat Rev Gastroenterol Hepatol; 2012 Sep; 9(9):530-8. PubMed ID: 22710573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver stem cells and hepatocellular carcinoma.
    Mishra L; Banker T; Murray J; Byers S; Thenappan A; He AR; Shetty K; Johnson L; Reddy EP
    Hepatology; 2009 Jan; 49(1):318-29. PubMed ID: 19111019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer stem cells and hepatocellular carcinoma.
    Yao Z; Mishra L
    Cancer Biol Ther; 2009 Sep; 8(18):1691-8. PubMed ID: 19901516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-beta inactivation and TGF-alpha overexpression cooperate in an in vivo mouse model to induce hepatocellular carcinoma that recapitulates molecular features of human liver cancer.
    Baek JY; Morris SM; Campbell J; Fausto N; Yeh MM; Grady WM
    Int J Cancer; 2010 Sep; 127(5):1060-71. PubMed ID: 20020490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
    Xia H; Ooi LL; Hui KM
    Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal.
    Li Y; Jiang F; Liu Q; Shen J; Wang X; Li Z; Zhang J; Lu X
    Toxicol Sci; 2015 Jan; 143(1):156-64. PubMed ID: 25304214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular cancer arises from loss of transforming growth factor beta signaling adaptor protein embryonic liver fodrin through abnormal angiogenesis.
    Baek HJ; Lim SC; Kitisin K; Jogunoori W; Tang Y; Marshall MB; Mishra B; Kim TH; Cho KH; Kim SS; Mishra L
    Hepatology; 2008 Oct; 48(4):1128-37. PubMed ID: 18704924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biology of transforming growth factor beta in hepatocarcinogenesis.
    Rossmanith W; Schulte-Hermann R
    Microsc Res Tech; 2001 Feb; 52(4):430-6. PubMed ID: 11170302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-β-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma.
    Malfettone A; Soukupova J; Bertran E; Crosas-Molist E; Lastra R; Fernando J; Koudelkova P; Rani B; Fabra Á; Serrano T; Ramos E; Mikulits W; Giannelli G; Fabregat I
    Cancer Lett; 2017 Apr; 392():39-50. PubMed ID: 28161507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation therapy of hepatocellular carcinoma by inhibiting the activity of AKT/GSK-3β/β-catenin axis and TGF-β induced EMT with sophocarpine.
    Zhang PP; Wang PQ; Qiao CP; Zhang Q; Zhang JP; Chen F; Zhang X; Xie WF; Yuan ZL; Li ZS; Chen YX
    Cancer Lett; 2016 Jun; 376(1):95-103. PubMed ID: 26945965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growth.
    Senturk S; Mumcuoglu M; Gursoy-Yuzugullu O; Cingoz B; Akcali KC; Ozturk M
    Hepatology; 2010 Sep; 52(3):966-74. PubMed ID: 20583212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissecting the effect of targeting the epidermal growth factor receptor on TGF-β-induced-apoptosis in human hepatocellular carcinoma cells.
    Caja L; Sancho P; Bertran E; Fabregat I
    J Hepatol; 2011 Aug; 55(2):351-8. PubMed ID: 21147185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of the effects of PEGylated interferon-α2a versus 5-fluorouracil on cancer stem cells in a rat model of hepatocellular carcinoma.
    Motawi TK; El-Boghdady NA; El-Sayed AM; Helmy HS
    Tumour Biol; 2016 Feb; 37(2):1617-25. PubMed ID: 26304505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smad inhibitor induces CSC differentiation for effective chemosensitization in cyclin D1- and TGF-β/Smad-regulated liver cancer stem cell-like cells.
    Xia W; Lo CM; Poon RYC; Cheung TT; Chan ACY; Chen L; Yang S; Tsao GSW; Wang XQ
    Oncotarget; 2017 Jun; 8(24):38811-38824. PubMed ID: 28415588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
    Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX
    Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel therapeutic strategies for targeting liver cancer stem cells.
    Oishi N; Wang XW
    Int J Biol Sci; 2011 Apr; 7(5):517-35. PubMed ID: 21552419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2.
    Wang F; Yuan JH; Wang SB; Yang F; Yuan SX; Ye C; Yang N; Zhou WP; Li WL; Li W; Sun SH
    Hepatology; 2014 Oct; 60(4):1278-90. PubMed ID: 25043274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-β as Multifaceted Orchestrator in HCC Progression: Signaling, EMT, Immune Microenvironment, and Novel Therapeutic Perspectives.
    Dituri F; Mancarella S; Cigliano A; Chieti A; Giannelli G
    Semin Liver Dis; 2019 Feb; 39(1):53-69. PubMed ID: 30586675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
    Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
    Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoring miR122 in human stem-like hepatocarcinoma cells, prompts tumor dormancy through Smad-independent TGF-β pathway.
    Boix L; López-Oliva JM; Rhodes AC; Bruix J
    Oncotarget; 2016 Nov; 7(44):71309-71329. PubMed ID: 27612430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.